Other Antibody References

Schmeisser H, Kontsek P, Esposito D, Gillette W, Schreiber G, Zoon KC (2006) Binding Characteristics of IFN-alpha Subvariants to IFNAR2-EC and Influence of the 6-Histidine Tag. J Interferon Cytokine Res 26(12):866-876.

Jarvik JW, Telmer CA (1998) Epitope tagging. Annu Rev Genet 32:601-618.

ACTH

Bloch B, Gaillard RC, Brazeau P, Lin HD, Ling N (1984) Topographical and ontogenetic study of the neurons producing growth hormone-releasing factor in human hypothalamus. Regul Pept 8(1):21-31.

Baird A, Wehrenberg WB, Shibasaki T, Benoit R, Chong-Li Z, Esch F, Ling N (1982) Ovine corticotropin-releasing factor stimulates the concomitant secretion of corticotropin, beta-lipotropin, beta-endorphin and gamma-melanotropin by the bovine adenohypophysis in vitro. Biochem Biophys Res Commun 108(3):959-964.

Rossier J, Vargo TM, Minick S, Ling N, Bloom FE, Guillemin R (1977) Regional dissociation of beta-endorphin and enkephalin contents in rat brain and pituitary. Proc Natl Acad Sci USA 74(11):5162-5165.

actMMP-9

Duncan ME, Richardson JP, Murray GI, Melvin WT, Fothergill JE (1998) Human matrix metalloproteinase-9: Activation by limited trypsin treatment and generation of monoclonal antibodies specific for the activated form. Eur J Biochem 258:37-43.

BAM 22P

Lembo PM, Grazzini E, Groblewski T, O'Donnell D, Roy MO, Zhang J, Hoffert C, Cao J, Schmidt R, Pelletier M, Labarre M, Gosselin M, Fortin Y, Banville D, Shen SH, Strom P, Payza K, Dray A, Walker P, Ahmad S (2002) Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs. Nat Neurosci 5(3):201-209.

Baird A, Klepper R, Ling N (1984) In vitro and in vivo evidence that the C-terminus of preproenkephalin-A circulates as an 8500-dalton molecule. Proc Soc Exp Biol Med 175(3):304-308.

Bloch B, Baird A, Ling N, Benoit R, Guillemin R (1983) Immunohistochemical evidence that brain enkephalins arise from a precursor similar to adrenal preproenkephalin. Brain Res 263:251-257.

BAM 12P

Bloch B, Baird A, Ling N, Benoit R, Guillemin R (1983) Immunohistochemical evidence that brain enkephalins arise from a precursor similar to adrenal preproenkephalin. Brain Res 263:251-257.

Baird A, Ling N, Bohlen P, Benoit R, Klepper R, Guillemin R (1982) Molecular forms of the putative enkephalin precursor BAM-12P in bovine adrenal, pituitary, and hypothalamus. Proc Natl Acad Sci USA 79:2023-2025.

CD22

Li JL, Shen GL, Ghetie MA, May RD, Till M, Ghetie V, Uhr JW, Janossy G, Thorpe PE, Amlot P, et al. (1989) The epitope specificity and tissue reactivity of four murine monoclonal anti-CD22 antibodies. Cell Immunol 118(1):85-99.

Shen GL, Li JL, Ghetie MA, Ghetie V, May RD, Till M, Brown AN, Relf M, Knowles P, Uhr JW, et al. (1988) Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas. Int J Cancer 42(5):792-797.

CD25, Human

Mavroudis DA, Jiang YZ, Hensel N, Lewalle P, Couriel D, Kreitman RJ, Pastan I, Barrett AJ (1996) Specific depletion of alloreactivity against haplotype mismatched related individuals by a recombinant immunotoxin: a new approach to graft-versus-host disease prophylaxis in haploidentical bone marrow transplantation. Bone Marrow Transplant 17:793-799.

Schnell R, Vitetta E, Schindler J, Barth S, Winkler U, Borchmann P, Hansmann ML, Diehl V, Ghetie V, Engert A (1988) Clinical trials with an anti-CD25 ricin A-chain experimental and immunotoxin (RFT5-SMPT-dgA) in Hodgkin's lymphoma. Leuk Lymphoma 30:525-537.

Depper JM, Leonard WJ, Robb RJ, Waldmann TA, Greene WC (1983) Blockade of the interleukin-2 receptor by anti-Tac antibody: Inhibition of human lymphocyte activation. J Immunol 131(2):690-696.

Uchiyama T, Broder S, Waldmann TA (1981) A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells. J Immunol 126(4):1393-1397.

Uchiyama T, Nelson DL, Fleisher TA, Waldmann TA (1981) A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells. J Immunol 126(4):1398-1403.

CD25, Mouse

Rusterholz C, Henrioud PC, Nabholz M(1999) Interleukin-2 (IL-2) regulates the accessibility of the IL-2-responsive enhancer in the IL-2 receptor alpha gene to transcription factors. Mol Cell Biol 19(4):2681-2689.

Lowenthal JW, Corthesy P, Tougne C, Lees R, MacDonald HR, Nabholz M (1985) High and low affinity IL 2 receptors: analysis by IL 2 dissociation rate and reactivity with monoclonal anti-receptor antibody PC61. J Immunol 135(6):3988-3994.

Lowenthal JW, Zubler RH, Nabholz M, MacDonald HR (1985) Similarities between interleukin-2 receptor number and affinity on activated B and T lymphocytes. Nature 315(6021):669-672.

CD4

Belton RJ Jr (2008) Basigin-2 is a cell surface receptor for soluble basigin ligand. J Biol Chem 283(26):17805-17814.

Corticotropin Releasing Hormone (CRH/CRF)

Wagle M, Mathur P, Guo S. (2011) Corticotropin-releasing factor critical for zebrafish camouflage behavior is regulated by light and sensitive to ethanol. J Neurosci 31(1):214-224. (Targeting Trends online summary)

Kublaoui BM, Gemelli T, Tolson KP, Wang Y, Zinn AR (2008) Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol Endocrinol 22(7):1723-1734. (Targeting Trends online summary)

Xu J, Xu F, Hennebold JD, Molskness TA, Stouffer RL (2007) Expression and role of the corticotropin-releasing hormone/urocortin-receptor-binding protein system in the primate corpus luteum during the menstrual cycle. Endocrinology 148(11):5385-5395.

Anton PM, Gay J, Mykoniatis A, Pan A, O'Brien M, Brown D, Karalis K, Pothoulakis C (2004) Corticotropin-releasing hormone (CRH) requirement in Clostridium difficile toxin A-mediated intestinal inflammation. Proc Natl Acad Sci U S A 101(22):8503-8508.

Widmaier EP, Lim AT, Vale W (1989) Secretion of corticotropin-releasing factor from cultured rat hypothalamic cells: effects of catecholamines. Endocrinology 124:583-590.

Bloch B, Gaillard RC, Brazeau P, Lin HD, Ling N (1984) Topographical and ontogenetic study of the neurons producing growth hormone-releasing factor in human hypothalamus. Regul Pept 8(1):21-31.

Vale W, Vaughan J, Yamamoto G, Bruhn T, Douglas C, Dalton D, Rivier C, Rivier J (1983) Assay of corticotropin releasing factor. Methods Enzymol 103:565-577.

Cytochrome P450 (CYP450)

Kumarakulasingham M, Rooney PH, Dundas SR, Telfer C, Melvin WT, Curran S, Murray GI (2005) Cytochrome p450 profile of colorectal cancer: identification of markers of prognosis. Clin Cancer Res 11(10):3758-3765.

Beta Endorphin

Guillemin R, Ling N, Vargo T (1977) Radioimmunoassays for a-endorphin and b-endorphin. Biochem Biophys Res Commun 77(1):361-366.

[Leu⁵]Enkephalin

basic Fibroblast Growth Factor, (FGF-2)

Houchen CW, George RJ, Sturmoski MA, Cohn SM (1999) FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury. Am J Physiol 276(1 Pt 1):G249-58.

Gonzalez AM, Berry M, Maher PA, Logan A, Baird A (1995) A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain. Brain Res 701:201-226.

Gonzalez AM, Buscaglia M, Ong M, Baird A (1990) Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J Cell Biol 110:753-765.

Growth Hormone Releasing Hormone (GHRH/GHRF)

Bloch B, Baird A, Ling N, Guillemin R (1986) Immunohistochemical evidence that growth hormone-releasing factor (GRF) neurons contain an amidated peptide derived from cleavage of the carboxyl-terminal end of the GRF precursor. Endocrinology 118:156-162.

Bloch B, Gaillard RC, Brazeau P, Lin HD, Ling N (1984) Topographical and ontogenetic study of the neurons producing growth hormone-releasing factor in human hypothalamus. Regul Pept 8(1):21-31.

Bloch B, Brazeau P, Ling N, Bohlen P, Esch F, Wehrenberg WB, Benoit R, Bloom F, Guillemin R (1983) Immunohistochemical detection of growth hormone-releasing factor in brain. Nature 301:607-608.

Luteinizing Hormone-Releasing Hormone (LHRH)

Bloch B, Gaillard RC, Brazeau P, Lin HD, Ling N (1984) Topographical and ontogenetic study of the neurons producing growth hormone-releasing factor in human hypothalamus. Regul Pept 8(1):21-31.

MMP-9

Murray GI, Duncan ME, Arbuckle E, Melvin WT, Fothergill JE (1998) Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 43:791-797.

MSH-gamma-1

Randle JC, Moor BC, Kraicer J (1983) Differential control of the release of pro-opiomelanocortin-derived peptides from the pars intermedia of the rat pituitary. Response to serotonin. Neuroendocrinol 37:131-140.

Bohlen P, Esch F, Shibasaki T, Baird A, Ling N, Guillemin R (1981) Isolation and characterization of a gamma 1-melanotropin-like peptide from bovine neurointermediate pituitary. FEBS Lett 128(1):67-70.

Shibasaki T, Ling N, Guillemin R, Silver M, Bloom F (1981) The regional distribution of gamma 3-melanotropin-like peptides in bovine brain is correlated with adrenocorticotropin immunoreactivity but not with beta-endorphin. Reg Peptides 2:43-52.

Bloom FE, Battenberg EL, Shibasaki T, Benoit R, Ling N, Guillemin R (1980) Localization of gamma-melanocyte stimulating hormone (gamma MSH) immunoreactivity in rat brain and pituitary. Reg Peptides 1:205-222.

Shibasaki T, Ling N, Guillemin R. (1980) A radioimmunoassay for gamma 1-melanotropin and evidence that the smallest pituitary gamma-melanotropin is amidated at the COOH-terminus. Biochem Biophys Res Commun 96(3):1393-1399.

NSE

Murray GI, Duncan ME, Melvin WT, Fothergill JE (1993) Immunohistochemistry of neurone specific enolase with gamma subunit specific anti-peptide monoclonal antibodies. J Clin Pathol 46(11):993-996.

Duncan ME, McAleese SM, Booth NA, Melvin WT, Fothergill JE (1992) A simple enzyme-linked immunosorbent assay (ELISA) for the neuron-specific gamma isozyme of human enolase (NSE) using monoclonal antibodies raised against synthetic peptides corresponding to isozyme sequence differences. J Immunol Methods 151(1-2):227-236.

p70 S6K

Fiedler J, Strauss G, Wannack M, Schwiebert S, Seidel K, Henning K, Klopocki E, Schmugge M, Gaedicke G, Schulze H. (2012) Two patterns of thrombopoietin signaling suggest no coupling between platelet production and thrombopoietin reactivity in thrombocytopenia-absent radii syndrome. Haematologica 97(1):73-81. (Targeting Trends 12q2)

Saporin, Goat Polyclonal

Hutchins BM, Kazane SA, Staflin K, Forsyth JS, Felding-Habermann B, Smider VV, Schultz PG. (2011) Selective formation of covalent protein heterodimers with an unnatural amino acid. Chem Biol 18(3):299-303. (Targeting Trends online summary)

Marshall RS, D'Avila F, Di Cola A, Traini R, Spano L, Fabbrini MS, Ceriotti A. (2011) Signal peptide-regulated toxicity of a plant ribosome-inactivating protein during cell stress. Plant J 65(2):218-229. (Targeting Trends online summary)

Vulchanova L, Olson TH, Stone LS, Riedl MS, Elde R, Honda CN (2001) Cytotoxic targeting of isolectin IB4-binding sensory neurons. Neuroscience 108(1):143-155.

Waite JJ, Chen AD (2001) Differential changes in rat cholinergic parameters subsequent to immunotoxic lesion of the basal forebrain nuclei. Brain Res 918:113-120.

Fabbrini MS, Carpani D, Soria MR, Ceriotti A (2000) Cytosolic immunization allows the expression of preATF-saporin chimeric toxin in eukaryotic cells. FASEB J 14(2):391-398.

Mantyh PW, Rogers SD, Honore P, Allen BJ, Ghilardi JR, Li J, Daughters RS, Lappi DA, Wiley RG, Simone DA (1997) Inhibition of hyperalgesia by ablation of lamina I spinal neurons expressing the substance P receptor. Science 278:275-279.

Stirpe F, Barbieri L, Battelli MG, Soria M, Lappi DA (1992) Ribosome-inactivating proteins from plants: present status and future prospects. Bio/Technol 10:405-412.

Lappi DA, Esch FS, Barbieri L, Stirpe F, Soria M (1985) Characterization of a Saponaria officinalis seed ribosome-inactivating protein: immunoreactivity and sequence homologies. Biochem Biophys Res Commun 129:934-942.

Stirpe F, Gasperi-Campani A, Barbieri L, Falasca A, Abbondanza A, Stevens WA (1983) Ribosome-inactivating proteins from the seeds of Saponaria officinalis L. (soapwort) of Agrostemma githago L. (corn cockle) and of Asparagus officinalis (asparagus) and from the latex of Hura crepitans L. (sandbox tree). Biochem J 216:617-625.

Saporin, HRP-labeled Goat Polyclonal

Vulchanova L, Olson TH, Stone LS, Riedl MS, Elde R, Honda CN (2001) Cytotoxic targeting of isolectin IB4-binding sensory neurons. Neuroscience 108(1):143-155.

Sauvagine

Brown MR, Fisher LA, Spiess J, Rivier J, Rivier C, Vale W (1982) Comparison of the biologic actions of corticotropin-releasing factor and sauvagine. Reg Peptides 4:107-114.

SCD-1

Ariyama H, Kono N, Matsuda S, Inoue T, Arai H (2010) Decrease in membrane phospholipid unsaturation induces unfolded protein response. J Biol Chem 285(29):22027-22035. (Targeting Trends online summary)

Somatostatin-14 and Somatostatin-28

Kim DM, Ahn CW, Kim KR, Hong SW, Nam MS, Cha BS, Lim SK, Lee HC, Lee EJ (2005) Duodenal somatostatinoma associated with diabetic ketoacidosis presumably caused by somatostatin-28 hypersecretion. J Clin Endocrinol Metab 90(11):6310-6315.

Bloch B, Gaillard RC, Brazeau P, Lin HD, Ling N (1984) Topographical and ontogenetic study of the neurons producing growth hormone-releasing factor in human hypothalamus. Regul Pept 8(1):21-31.

Benoit R, Ling N, Alford B, Guillemin R (1982) Seven peptides derived from pro-somatostatin in rat brain. Biochem Biophys Res Commun 107(3):944-950.

Benoit R, Bohlen P, Ling N, Briskin A, Esch F, Brazeau P, Ying SY, Guillemin R (1982) Presence of somatostatin-28-(1-12) in hypothalamus and pancreas. Proc Natl Acad Sci USA 79:917-921.

Telomeric Repeat Binding Factor 1 (TRF1)

Gilley D, Tanaka H, Herbert BS (2005) Telomere dysfunction in aging and cancer. Int J Biochem Cell Biol 37(5):1000-1013.

Angele S, Falconer A, Foster CS, Taniere P, Eeles RA, Hall J (2004) ATM protein overexpression in prostate tumors: possible role in telomere maintenance. Am J Clin Pathol 121(2):231-236.

van Steensel B, de Lange T (1997) Control of telomere length by the human telomeric protein TRF1. Nature 385(6618):740-743.